Shuang Yang1, Tianyi Qian2, Yao Meng3, Fei Gao1, Josef Pfeuffer4, Guangbin Wang1, and Bin Zhao1
1Shandong Medical Imaging Research Institute, Shandong University, Jinan, China, People's Republic of, 2Siemens Healthcare, MR Collaborations NE Asia, Beijing, China, People's Republic of, 3Shandong provincial Hospital, Shandong University, Jinan, China, People's Republic of, 4Siemens Healthcare, Application Development, Erlangen, Germany
Synopsis
This
study aims to present the feasibility of multi-TI (mTI)-ASL in distinguishing
between AD and SIVD patients in cerebral perfusion. Nineteen SIVD subjects,
twelve AD subjects, and ten controls were included in the study. There was no
significant difference in CBF between SIVD and HCs, and between SIVD and AD
patients. However, significant differences of BAT were detected among all three
groups. The mTI-ASL could evaluate the cerebral perfusion of AD and SIVD
patients. Compared with CBF, the BAT could better detect perfusion differences
and demonstrated better efficiency.Purpose
Vascular
dementia (VaD) is a relatively heterogeneous disease with various vascular
etiologies and has become the second most common cause of dementia in elderly
people. With recent advances in embolic stroke prevention, subcortical ischemic
vascular dementia (SIVD) has become one of the most common types of VaD. Early
detection and management of SIVD in the elderly is critical. Previous studies
have proven that subcortical ischemic lesions may cause general cognitive dysfunction
and poor physical health. Multi-TI arterial spin-labeling (mTI-ASL) MR
sequences measure the perfusion with multiple transit times after labeling and
can provide timing information such as bolus arrival time (BAT) and more
accurately quantify regional cerebral blood flow (CBF). This study investigates
the feasibility of mTI-ASL in detecting the difference in cerebral perfusion between
AD and SIVD patients, especially in BAT and CBF.
Methods
Nineteen
SIVD subjects (7 males, mean age 66.7 years), twelve AD subjects (5 males, mean
age 65.6 years), and ten healthy controls (HCs) (4 males, mean age 62.5 years)
were included in the study. The diagnosis of SIVD was based on a modified version
of criteria from the National Institute of Neurological Disorders and Stroke
and the Association Internationale pour Ia Recherche' et l'Enseignement en
Neurosciences (NINDS–AIREN).
1 The AD sample met the NINCDS-ADRDA
criteria for probable AD of mild–moderate severity.
2 Participants
were scanned using a MAGNETOM Skyra 3T MR scanner (Siemens Healthcare,
Erlangen, Germany) with a 32-channel head coil. The mTI-ASL images were
acquired with a prototype sequence with the following parameters: TR/TE =
4600/22 ms, FOV = 220 × 220 mm
2, iPAT mode = GRAPPA (PE) 2, slice
thickness = 4 mm, voxel size = 3.4 × 3.4 × 4.0 mm
3, 20 slices, bolus
length = 700 ms, 16 TIs from 480 to 4080 ms, and total acquisition time = 5:09
min including an M0 scan. The Buxton model with
a non-linear fit to CBF and BAT was used for quantification. The group
analysis of BAT and CBF were post-processed with SPM8 (Wellcome Department of
Cognitive Neurology, London, UK).
Results
Voxel-based
analysis (VBA) was performed to compare the AD, SIVD and HC groups. Age, sex,
education, Mini Mental State Examination (MMSE) scores and gray matter volume
were all considered as covariant factors. Compared to HCs, the CBF decreased in
the bilateral frontal lobe of AD patients including in the left superior
frontal gyrus, middle frontal gyrus, Brodmann area 10 (anterior prefrontal
cortex) and right superior frontal gyrus. The BAT demonstrated prolonged characters
in corresponding decreased CBF areas compared to HCs. (Figure 1) There was no
significant difference in CBF between SIVD and HCs, and between SIVD and AD
patients. However, significant prolongation was detected in Brodmann area 19 (associative
visual cortex) of BAT in SIVD patients compared to HCs. In comparison between
AD and SIVD patients, BAT was significantly prolonged in the bilateral frontal
lobe, left dorsal thalamus and right parietal lobe in AD patients. (Figure 2)
Discussion
Single-TI
ASL (sTI-ASL) experiments cannot detect the highest CBF for all brain areas,
especially for patients who may have prolonged artery transit time (ATT) compared
to normal subjects. So the decrease of CBF and increase of ATT show low CBF in
the sTI-ASL results that lead to the underestimation of CBF. The mTI-ASL could
provide both quantitative BAT (ATT) and CBF, so that we learn more about the
mechanism and how to treat AD and SIVD.
Conclusion
The
CBF decreased more in the frontal lobe of AD patients compared with healthy
controls, and the BAT maps demonstrated an opposite tendency compared to CBF.
The mTI-ASL could be used to evaluate the cerebral perfusion of AD and SIVD
patients both in CBF and BAT and could detect perfusion deficits more
accurately and efficiently compared with CBF.
Acknowledgements
No acknowledgement found.References
1.
Erkinjuntti T,
Inzitari D, Pantoni L, et al. Research criteria for subcortical vascular
dementia in clinical trials. Journal of neural transmission. Supplementum. 2000;
59: 23-30.
2.
McKhann G,
Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of
Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices
of Department of Health and Human Services Task Force on Alzheimer’s Disease.
Neurology 1984; 34: 939-944.